CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Solaiman Shereen Chief People Officer | Grant or award · Time-Based Stock Option | +83,049 | 83,049 | ||
| 2026-03-14 | Solaiman Shereen Chief People Officer | Shares withheld for taxes | −5,784 | $4.66 | $27K | 267,801 |
| 2026-03-13 | Solaiman Shereen Chief People Officer | Shares withheld for taxes | −8,899 | $4.66 | $41K | 273,585 |
| 2026-03-12 | Solaiman Shereen Chief People Officer | Grant or award | +173,196 | 282,484 | ||
| 2026-03-01 | Solaiman Shereen Chief People Officer | Shares withheld for taxes | −1,675 | $4.61 | $8K | 109,288 |
| 2025-03-14 | Solaiman Shereen Chief People Officer | Shares withheld for taxes | −6,060 | $10.07 | $61K | 110,963 |
| 2025-03-13 | Solaiman Shereen Chief People Officer | Grant or award | +63,145 | 117,023 | ||
| 2025-03-01 | Solaiman Shereen Chief People Officer | Shares withheld for taxes | −1,912 | $10.73 | $21K | 53,878 |
| 2024-03-14 | Solaiman Shereen Chief People Officer | Grant or award | +41,042 | 55,790 | ||
| 2024-03-01 | Solaiman Shereen Chief People Officer | Shares withheld for taxes | −1,108 | $22.18 | $25K | 14,748 |
| 2023-03-01 | Solaiman Shereen Chief People Officer | Grant or award | +15,856 | 15,856 |
Page 1 of 1 · 11 trades